文献速递中枢神经肿瘤放疗放疗物理与技术

脑转移瘤切除术后5次立体定向放疗的放射性坏死剂量学因素

Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
PubMed 文献 · Pract Radiat Oncol · 2019-10-03

该单中心回顾性研究纳入2008至2016年55个脑转移瘤切除术后接受5次直线加速器立体定向放疗(25-35 Gy)的病灶,评估与影像学放射性坏死相关的剂量学参数。1年放射性坏死累积发生率为18.2%,最大热点及计划靶区外扩边缘内相对热点(105%、110%、111%)和绝对剂量33.5 Gy与放射性坏死相关,而临床靶区内的热点不相关。

要点

  • 术后5次SRS后1年影像学放射性坏死累积发生率为18.2%。
  • 计划靶区外扩边缘内热点(105%-111%或33.5 Gy)预测放射性坏死,临床靶区内热点不预测。

核心结论

  • 最大热点和计划靶区外扩边缘内热点的位置与幅度与术后5次SRS后放射性坏死风险相关,临床靶区内热点不相关。

研究设计与样本

  • 单中心回顾性研究,2008至2016年55个脑转移瘤切除术后接受5次直线加速器立体定向放疗(25-35 Gy)的病灶,随访至少3个月。

主要发现

  • 全部患者中位年龄58.5岁,全部靶区中位临床靶区体积17.53 cm3,中位计划靶区外扩边缘2 mm,中位最大热点111%。
  • 1年影像学放射性坏死累积发生率为18.2%。

关键数值与推荐

  • 计划靶区外扩边缘内热点相对幅度105%、110%、111%和绝对剂量33.5 Gy为预测放射性坏死的切点。

临床怎么用

  • 制定术后5次SRS计划时应关注热点位置与幅度,尤其避免计划靶区外扩边缘内出现105%-111%或33.5 Gy的热点。

局限性

  • 单中心回顾性设计,样本量55个病灶,随访至少3个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Stereotactic radiosurgery (SRS) is increasingly used in the management of patients with resected brain metastases (rBMs). A significant complication of this therapy can be radiation necrosis (RN). Despite radiation therapy dose de-escalation and the delivery of several rather than a single dose fraction, rates of RN after SRS for rBMs remain high. We evaluated the dosimetric parameters associated with radiographic RN for rBMs. METHODS AND MATERIALS: From 2008 to 2016, 55 rBMs at a single institution that were treated postoperatively with 5-fraction linear accelerator-based SRS (25-35 Gy) with minimum 3 months follow-up were evaluated. For each lesion, variables recorded included radiation therapy dose to normal brain, location and magnitude of hotspots, clinical target volume (CTV), and margin size. Hotspot location was stratified as within the tumor bed alone (CTV) or within the planning target volume (PTV) expansion margin volume (PTV minus CTV). Cumulative incidence with competing risks was used to estimate rates of RN and local recurrence. Optimal cut-points predicting for RN for hotspot magnitude based on location were identified via maximization of the log-rank test statistic. RESULTS: Median age for all patients was 58.5 years. For all targets, the median CTV was 17.53 cm3, the median expansion margin to PTV was 2 mm, and the median max hotspot was 111%. At 1 year, cumulative incidence of radiographic RN was 18.2%. Univariate analysis showed that max hotspots with a hazard ratio of 3.28 (P = .045), hotspots within the PTV expansion margin with relative magnitudes of 105%, 110%, and 111%, and an absolute dose of 33.5 Gy predicted for RN (P = .029, P = .04, P = .038, and P = .0488, respectively), but hotspots within the CTV did not. CONCLUSIONS: To our knowledge, this is the first study that investigated dosimetric factors that predict for RN after 5-fraction hypofractionated SRS for rBM. Hotspot location and magnitude appear important for predicting RN risk, thus these parameters should be carefully considered during treatment planning.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Tanenbaum DG, Buchwald ZS, Jhaveri J, et al. Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases. Pract Radiat Oncol. 2019. PMID: 31586666. doi:10.1016/j.prro.2019.09.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。